552 related articles for article (PubMed ID: 29709420)
21. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock.
Luyt CE; Landivier A; Leprince P; Bernard M; Pavie A; Chastre J; Combes A
J Crit Care; 2012 Oct; 27(5):524.e7-14. PubMed ID: 22386227
[TBL] [Abstract][Full Text] [Related]
22. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
[TBL] [Abstract][Full Text] [Related]
23. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
24. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit.
Jentzer JC; van Diepen S; Barsness GW; Henry TD; Menon V; Rihal CS; Naidu SS; Baran DA
J Am Coll Cardiol; 2019 Oct; 74(17):2117-2128. PubMed ID: 31548097
[TBL] [Abstract][Full Text] [Related]
25. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
[TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Potapov EV; Hennig F; Wagner FD; Volk HD; Sodian R; Hausmann H; Lehmkuhl HB; Hetzer R
Eur J Cardiothorac Surg; 2005 May; 27(5):899-905. PubMed ID: 15848333
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
Andrié RP; Becher UM; Frommold R; Tiyerili V; Schrickel JW; Nickenig G; Schwab JO
Crit Care; 2012 Aug; 16(4):R152. PubMed ID: 22889197
[TBL] [Abstract][Full Text] [Related]
28. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
[TBL] [Abstract][Full Text] [Related]
29. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
30. Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure.
Rudiger A; Businger F; Streit M; Schmid ER; Maggiorini M; Follath F
Swiss Med Wkly; 2009 Feb; 139(7-8):110-6. PubMed ID: 19234879
[TBL] [Abstract][Full Text] [Related]
31. Time of onset and outcome of cardiogenic shock in acute coronary syndromes.
Valente S; Lazzeri C; Chiostri M; Sori A; Giglioli C; Salvadori C; Gensini GF
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1235-40. PubMed ID: 19001930
[TBL] [Abstract][Full Text] [Related]
32. Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study.
Wang Y; Fu L; Jia Q; Yu H; Zhang P; Zhang C; Huang X; He K; Tian Y
Biomed Res Int; 2016; 2016():7496061. PubMed ID: 27144175
[TBL] [Abstract][Full Text] [Related]
33. Transradial versus transfemoral approach for percutaneous coronary intervention in cardiogenic shock: A radial-first centre experience and meta-analysis of published studies.
Roule V; Lemaitre A; Sabatier R; Lognoné T; Dahdouh Z; Berger L; Milliez P; Grollier G; Montalescot G; Beygui F
Arch Cardiovasc Dis; 2015 Nov; 108(11):563-75. PubMed ID: 26365478
[TBL] [Abstract][Full Text] [Related]
34. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
[TBL] [Abstract][Full Text] [Related]
35. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
[TBL] [Abstract][Full Text] [Related]
36. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry.
Sakamoto K; Matoba T; Mohri M; Ueki Y; Tsujita Y; Yamasaki M; Tanaka N; Hokama Y; Fukutomi M; Hashiba K; Fukuhara R; Suwa S; Matsuura H; Tachibana E; Yonemoto N; Nagao K
Heart Vessels; 2019 Aug; 34(8):1241-1249. PubMed ID: 30715570
[TBL] [Abstract][Full Text] [Related]
38. Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres.
Barrionuevo-Sánchez MI; Viana-Tejedor A; Ariza-Solé A; Del Prado N; Rosillo N; Sánchez-Salado JC; Lorente V; Jorge-Pérez P; Noriega FJ; Ferrera C; Alegre O; Llaó I; Bernal JL; Triguero L; Fernández-Pérez C; González-Costello J; Marcos M; de la Cuerda F; Carmona J; Cequier A; Fernández-Ortiz A; Pérez-Villacastín J; Comin-Colet J; Elola FJ
Eur Heart J Acute Cardiovasc Care; 2023 Jul; 12(7):422-429. PubMed ID: 37294681
[TBL] [Abstract][Full Text] [Related]
39. [The predictive value of plasma N-terminal pro-B-type natriuretic peptide levels in the evaluation of prognosis and the severity of patients with septic shock induced myocardial suppression].
Chen W; Zhao L; Liu P; Sheng B; Zhen J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):40-4. PubMed ID: 23611096
[TBL] [Abstract][Full Text] [Related]
40. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
